In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Kimia Biosciences has informed that the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) shall remain closed from Friday, 01.10.2021 up to the completion of 48 hours after the declaration of unaudited Financial Results for the 2nd quarter ended 30th September 2021 to the Stock Exchange. The date of meeting of Board of Directors to consider and approve the unaudited financial results for the 2nd quarter shall be communicated in due course.
The above information is a part of company’s filings submitted to BSE.
